Less Ads, More Data, More Tools Register for FREE

Pin to quick picksServision PLC Regulatory News (SEV)

  • There is currently no data for SEV

Shareholder loan and related party transaction

24 Feb 2016 16:00

RNS Number : 0548Q
SerVision plc
24 February 2016
 

24 February 2016

 

SerVision plc

("SerVision" or the "Company")

 

Shareholder loan and related party transaction

 

SerVision (AIM: SEV), the AIM quoted developer and manufacturer of digital video security systems, announces that, on 23 February 2016, the Company entered into an agreement (the "Loan Agreement") with Gabriel Sassoon, an existing shareholder in the Company, to provide the Company with an unsecured working capital loan facility of US$1.0 million (equivalent to approximately £712,500 at the current prevailing exchange rate*) (the "Loan"). The Loan will be used to provide additional working capital facilities for the Company and supplement the Company's existing cash resources.

 

The key terms of the Loan pursuant to the Loan agreement are as follows:

 

· Loan amount: US$1,000,000

· The Loan carries an annual interest rate of 6%

· The Loan is repayable on 15 February 2019 (the "Repayment Date") or earlier at the sole discretion of SerVision

· The Company has the ability to repay the Loan on a monthly basis throughout the term of the Loan

· The Loan is unsecured

 

To the extent that the Company does not repay the outstanding amounts on the Loan as at the Repayment Date then the Company will be obliged to issue new ordinary shares in the Company (the "Conversion Shares") to Gabriel Sassoon to satisfy the outstanding amounts due to him under the Loan Agreement. In such circumstances the issue price of the Conversion Shares would be calculated on the basis of the average closing mid-market price of the Company's ordinary shares for the calendar month prior to the Repayment Date, subject to the issue price of the Conversion Shares being no less than 3.5 pence per share (a 40 per cent. premium to the closing mid-market price of the Company's shares as at 23 February 2016).

 

Gabriel Sassoon is interested in 18,992,956 ordinary shares of 1 pence each in the Company, representing 14.98 per cent. of the current issued share capital of SerVision. Given that Gabriel Sassoon is a substantial shareholder in the Company, the provision of the Loan is a related party transaction pursuant to Rule 13 of the AIM Rules for Companies. The Directors consider, having consulted with Allenby Capital Limited, the Company's nominated adviser, that the terms of the Loan are fair and reasonable insofar as the Company's shareholders are concerned.

 

-ends-

 

SerVision plc

+972 2535 0000

Gidon Tahan, Chairman and CEO

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0)20 3328 5656

Nick Athanas / James Reeve 

 

Beaufort Securities Limited (Joint Broker)

Jon Levinson / Elliot Hance

+44 (0)20 7382 8300

 

Cadogan Leander (Financial PR)

Christian Taylor-Wilkinson

+44 (0)7795 168 157

 

*Based on exchange rate of 1GBP = 1.40322USD as at 23 February 2016

 

Notes to Editors

 

SerVision is a pioneer in the field of security communications technology and a leading developer and manufacturer of fully integrated video recording and transmission systems for homeland security and transportation applications. The Company's core technology is proprietary video compression which is optimised for streaming real-time video over any type of cellular or narrowband network.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASALASKKEFF
Date   Source Headline
28th Jun 20185:00 pmRNSProposed Appointment of Liquidator
14th Jun 20187:00 amRNSUpdate re. proposed sale of SerVision Limited
5th Jun 201811:57 amRNSUpdate re. proposed sale of SerVision Limited
24th May 20183:29 pmRNSUpdate re. SerVision Limited and suspension
27th Apr 20185:13 pmRNSUpdate re. SerVision Limited and suspension
18th Apr 20187:00 amRNSUpdate re. SerVision Limited and suspension
29th Mar 20189:08 amRNSUpdate re suspension
26th Mar 20183:21 pmRNSUpdate re suspension and Court hearing
19th Mar 20183:52 pmRNSUpdate re suspension
13th Mar 20187:00 amRNSUpdate re Suspension
20th Feb 201812:08 pmRNSSuspension of Trading
20th Feb 201810:30 amRNSSuspension - SerVision Plc
13th Feb 201810:33 amRNSTrading update
1st Dec 201711:16 amRNSChange of Broker
28th Sep 201711:52 amRNSHalf-year Report
24th Aug 201712:34 pmRNSResult of AGM
17th Aug 20177:00 amRNSAmendment to YA Facility
31st Jul 20173:30 pmRNSNotice of AGM
18th Jul 20177:00 amRNSNew Contract
10th Jul 201711:30 amRNSResult of EGM
30th Jun 20171:30 pmRNSFinal Results
15th Jun 201710:30 amRNSNotice of EGM & Trading Statement
31st May 20174:30 pmRNSTotal Voting Rights
25th May 20177:38 amRNSSubscription - Receipt of Second Payment
31st Mar 20179:30 amRNSTotal Voting Rights
28th Mar 201712:31 pmRNSHolding(s) in Company
9th Mar 201712:30 pmRNSExercise of Warrants and Issue of Equity
1st Mar 20177:00 amRNSSubscription - Receipt of First Payment
23rd Feb 20174:56 pmRNSDirector/PDMR Shareholding
22nd Feb 20177:00 amRNSSubscription for $2 million
19th Dec 20167:00 amRNSNew Customer Orders
7th Dec 20167:18 amRNSShort Term Loan - replacement
7th Dec 20167:00 amRNSShort Term Loan
30th Sep 20167:00 amRNSInterim Results
1st Aug 201612:00 pmRNSDirectorate Change
26th Jul 201611:45 amRNSResult of AGM
8th Jul 201610:00 amRNSVariation of Loan Agreement and SEDA and Draw Down
30th Jun 20165:38 pmRNSFinal Results
14th Apr 20167:00 amRNSPresentation for Shareholders
5th Apr 20164:16 pmRNSChange of Registered Office
21st Mar 20167:00 amRNSUK Business Update
24th Feb 20164:00 pmRNSShareholder loan and related party transaction
25th Jan 20167:54 amRNSDistribution Agreement
1st Dec 20151:45 pmRNSTotal Voting Rights
26th Nov 20153:35 pmRNSResult of General Meeting
20th Nov 20157:00 amRNSContract Wins
2nd Nov 201511:00 amRNSNotice of General Meeting
30th Oct 20157:00 amRNSSupply Agreement
30th Sep 20151:42 pmRNSHalf Yearly Report
25th Sep 20157:00 amRNSPlacing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.